The Janssen COVID‑19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID‑19) in individuals 18 years of age and older. There is no FDA-approved vaccine to prevent COVID‑19.
The following resources are intended to provide information or guidance related to the Janssen COVID‑19 Vaccine and COVID‑19.
EUA Fact Sheet for Recipients and Caregivers
Download the EUA Fact Sheet for the Janssen COVID-19 Vaccine.Download
FDA EUA Letter for the Janssen COVID-19 Vaccine
Download the FDA's EUA Letter for the Janssen COVID-19 Vaccine.Download
CDC Recommendation for COVID-19 Vaccine Use
Get more information on the CDC and FDA recommendation for use of Johnson & Johnson’s Janssen COVID-19 Vaccine.Learn More
Facts About COVID-19
Get the facts about COVID-19 from the Centers for Disease Control (CDC).Learn More
Johns Hopkins University Information About the Disease
Get more information about COVID-19 from Johns Hopkins University.Learn More
COVID-19 Vaccine Facts
Access helpful resources and COVID-19 Vaccine FAQs.Learn More
The Benefits of Getting Vaccinated
Find out how vaccines may help keep you from getting COVID-19 and may help build protection.Learn More
Find out where and which COVID-19 vaccines are available near you.Find Now
CDC=Centers for Disease Control and Prevention; COVID-19=coronavirus disease 2019; FDA=Food and Drug Administration.